Other medical trials in patients with non-Hodgkin's lymphoma [24] and sufferers with advanced malignancy [fourteen] have shown also that zosuquidar did not significantly impact the pharmacokinetics of doxorubicin and had reasonable effects around the pharmacokinetics of vincristine. These scientific trials approved that zosuquidar could safely administrated with daunorubicin, doxorubi... https://annelio776alh2.blogvivi.com/profile